Evidence map›Paper›PMID 32453288›Full record

Trial reportJournal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases2020

A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.

Jasvinder A Singh, Candace Green, Sarah Morgan, Amanda L Willig, Betty Darnell, Kenneth G Saag, Rick Weiss, Gary Cutter, Gerald McGwin

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jasvinder A SinghFrom the Medicine Service, VA Medical Center, Birmingham, AL.
Candace GreenDivision of Clinical Immunology and Rheumatology.
Sarah MorganDivision of Clinical Immunology and Rheumatology.
Amanda L WilligDivision of Infectious Diseases, Department of Medicine at School of Medicine.
Betty DarnellDepartment of Nutrition.
Kenneth G SaagDivision of Clinical Immunology and Rheumatology.
Rick WeissViocare, Princeton, NJ.
Gary CutterDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL.
Gerald McGwinDepartment of Epidemiology, School of Public Health.
Center for Rheumatology · USBirmingham VA Medical Center · USUniversity of Alabama at Birmingham · USViocare (United States) · US

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
NCATS NIH HHS UL1 TR001417NCATS NIH HHS UL1 TR003096
6 · The paper itself

Abstract

objectiveThe aim of this study was to conduct a 9-month pilot Internet randomized controlled trial (RCT) of cherry extract and diet modification in gout to assess the feasibility of an Internet study and obtain effect estimates.

methodsAfter providing online informed consent in response to Internet advertisements and social media or clinic flyers, 84 people with physician-confirmed gout were randomized to either cherry extract 3,600 mg/d (n = 41) or dietitian-assisted diet modification for gout (n = 43). All study outcomes were collected via Internet and phone calls. The primary objective was the feasibility of an Internet study, and secondary objectives were to obtain effect estimates for gout flares, functional ability assessed with the Health Assessment Questionnaire (HAQ), and adverse events (AEs) for future trials.

resultsOf the 84 people randomized, overall completion rates were more than 80% for most study procedures up to 6 months and similar for the 2 active comparators. Improvements were seen in gout flares and HAQ scores in cherry extract and diet modification groups at 9 months compared with baseline: gout flares per month, 0.22 versus 0.36 (p = 0.049) and 0.28 versus 0.31 (p = 0.76); proportion with any gout flare, 56% versus 98% (p < 0.0001) and 65% versus 98% (p = 0.0002); and mean ± standard deviation HAQ score, 0.28 ± 0.54 versus 0.55 ± 0.68 (p = 0.001) and 0.23 ± 0.40 versus 0.48 ± 0.61 (p = 0.06), respectively. Any AEs and gastrointestinal symptoms/AEs at 9 months in cherry extract and diet modification groups were 3% versus 0% and 28% versus 27%, respectively.

conclusionsAn Internet gout RCT is feasible for nonpharmacological gout treatments. A hypothesis-testing, large Internet RCT of cherry extract versus placebo is needed.

Indexed as

Diagnostic Self EvaluationFunctional StatusPlant ExtractsPrunus domesticaCapsulesDiet TherapyFeasibility StudiesFemaleGoutHumansInternet-Based InterventionMaleMiddle AgedPhytotherapySymptom AssessmentSymptom Flare UpCapsulesPlant Extracts

Identifiers

PMID32453288
PMCPMC8664374
OpenAlexW2914140446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.